These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


70 related items for PubMed ID: 8438481

  • 1. Selection and chimerization of a monoclonal CD4 antibody for heart transplantation.
    Reiter C, Meiser BM, Uberfuhr P, Wenke K, Reichenspurner H, Kreuzer E, Rieber EP, Riethmüller G, Reichart B.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):788-9. PubMed ID: 8438481
    [No Abstract] [Full Text] [Related]

  • 2. A new chimeric monoclonal CD4 antibody for prevention of rejection after heart transplantation.
    Meiser BM, Reiter C, Ebel M, Uberfuhr P, Wenke K, Reichenspurner H, Rieber E, Riethmüller G, Reichart B.
    Transplant Proc; 1992 Oct; 24(5):1734. PubMed ID: 1412816
    [No Abstract] [Full Text] [Related]

  • 3. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
    Norman DJ, Bennett WM, Cobanoglu A, Hershberger R, Hosenpud JD, Meyer MM, Misiti J, Ott G, Ratkovec R, Shihab F.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):802-3. PubMed ID: 8438490
    [No Abstract] [Full Text] [Related]

  • 4. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
    Lazarovits AI, Rochon J, Banks L, Hollomby DJ, Muirhead N, Jevnikar AM, White MJ, Amlot PL, Beauregard-Zollinger L, Stiller CR.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
    [No Abstract] [Full Text] [Related]

  • 5. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG, Koulmanda M, Mandel TE.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract] [Full Text] [Related]

  • 6. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 8. [Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody].
    Campana C.
    Ital Heart J Suppl; 2000 Jun; 1(6):838-9. PubMed ID: 11204021
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
    Watson CJ, Davies HS, Metcalfe SM, Cobbold SP, Rebello PR, Collier DS, Waldmann H, Calne RY.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
    Wang H, Hosiawa KA, Garcia B, Shum JB, Dutartre P, Kelvin DJ, Zhong R.
    Transplantation; 2003 May 15; 75(9):1475-81. PubMed ID: 12792500
    [Abstract] [Full Text] [Related]

  • 15. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S.
    Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499
    [Abstract] [Full Text] [Related]

  • 16. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract] [Full Text] [Related]

  • 17. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
    Kriaa F, Hiesse C, Alard P, Lantz O, Noury J, Charpentier B, Bazin H.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 1):817-9. PubMed ID: 8438496
    [No Abstract] [Full Text] [Related]

  • 18. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
    Ito T, Stepkowski SM, Shirakura R, Nakata S, Yamamoto S, Nozaki S, Miyata M, Matsuda H.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 2):885-7. PubMed ID: 8442257
    [No Abstract] [Full Text] [Related]

  • 19. Influence of donor-recipient HLA-DR matching on efficacy of anti-CD25 mAb in cardiac transplantation.
    Lietz K, Beniaminovitz A, Burke E, John R, Kocher A, Schuster M, Mancini D, Edwards N, Itescu S.
    Transplant Proc; 2001 Feb 18; 33(1-2):1018. PubMed ID: 11267171
    [No Abstract] [Full Text] [Related]

  • 20. Avenues for acquired immune tolerance.
    Wood KJ, Morris PJ.
    Semin Thorac Cardiovasc Surg; 1990 Apr 18; 2(2):189-97. PubMed ID: 2081227
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.